Informations générales (source: ClinicalTrials.gov)
Prognostic Value of Myocardial Perfusion Heterogeneity Assessed by Stress Single Photon Emission Computed Tomography (EVAPERF)
Interventional
N/A
University Hospital, Grenoble (Voir sur ClinicalTrials)
janvier 2015
juin 2022
29 juin 2024
Endothelial dysfunction has been demonstrated to be an early marker of coronary artery
disease (CAD). On the other hand, myocardial perfusion single photon emission computed
tomography (MP-SPECT) is a widely used technique for evaluation of patients with
suspected or known CAD.
Preliminary data suggest that myocardial perfusion heterogeneity (a potential surrogate
marker of endothelial dysfunction) can be assessed on conventional MP-SPECT, but its
additive and independent prognostic value over the presence of myocardial ischemia remain
unknown.
More over, factual data demonstrate that inhalation of particulate matters and gaz (NO2,
CO) from air pollution contributes to the development of cardiovascular diseases in the
short and long term. The role of air pollution in endothelial dysfunction has been
suggested.
Accordingly, the purpose of this study is to evaluate the prognostic value of myocardial
perfusion heterogeneity assessed by a new automatized image processing method applied to
routine MP-SPECT.
The second purpose is to evaluate the role of air pollution exposure in pathogenesis of
cardiovascular disease.
The main hypothesis is that the presence of myocardial perfusion heterogeneity is
predictive of 2-year cardiovascular events in patients referred to the Nuclear Cardiology
Department for routine evaluation of known or suspected CAD.
The second hypothesis is that microcirculatory coronary dysfunction is a causal link
between air pollution and cardiovascular disease.
Etablissements
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
University Hospital - 38000 - Grenoble - France | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Age > 18 years
- Clinical indication for myocardial perfusion imaging
- Age > 18 years
- Clinical indication for myocardial perfusion imaging
- Pregnancy
- Breast feeding women
- Severe comorbidity with life expectancy 6 months
- Left bundle branch block on ECG making heteogeneity analysis impossible
- Patient not resident in the Rhône-Alpes region